Markets:

Overview

News

Currencies

International

Treasuries

CASI Pharmaceuticals, Inc. - Ordinary Shares (NQ:CASI)

1.450 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 12, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CASI Pharmaceuticals, Inc. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >

CASI Pharmaceuticals Enters Into Definitive Agreement for the Divestiture of Assets in China

May 12, 2025

Via ACCESS Newswire

CASI Pharmaceuticals Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement

May 07, 2025

Via ACCESS Newswire

CASI Pharma Stock Rises On $20M Buyout Offer From CEO For China Business Operations: Retail Remains Extremely Bullish ↗

April 03, 2025

The company said that its special committee of the board of directors will evaluate the proposed transaction.

Via Stocktwits

CASI Pharmaceuticals Announces Receipt of An Updated Non-Binding Proposal to Acquire Entire China Business of the Company

April 03, 2025

Via ACCESS Newswire

Recap: CASI Pharmaceuticals Q4 Earnings ↗

March 28, 2024

Via Benzinga

CASI Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Business and Financial Results

March 31, 2025

Via ACCESS Newswire

CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Immune Thrombocytopenia

January 06, 2025

Via ACCESSWIRE

CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results

November 15, 2024

Via ACCESSWIRE

CASI Pharmaceuticals Receives CTA Approval From China's NMPA for CID-103 in Immune Thrombocytopenia

October 24, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 09, 2024

Via Benzinga

Earnings Scheduled For November 14, 2024 ↗

November 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 01, 2024

Via Benzinga

CASI Stock Earnings: CASI Pharmaceuticals Beats EPS, Misses Revenue for Q2 2024 ↗

August 16, 2024

CASI stock results show that CASI Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

3 Promising Biotech Stocks You Can Pick Up for Less Than $10 ↗

July 29, 2024

Healthcare innovations are big business. That said, biotech stocks under $10 may offer a higher ceiling thanks to their low price.

Via InvestorPlace

Week In Review: Fosun Pharma Plans $690 Million Deal To Privatize Henlius, Its Biologics Subsidiary ↗

June 30, 2024

Shanghai Henlius Biotech agreed to be a wholly owned subsidiary of Fosun in a $690 million deal that values the company at $1.7 billion. Meanwhile, Suzhou Ascentage Pharma filed to list in the US to...

Via Talk Markets

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

June 27, 2024

Pre-market stock movers are worth checking out on Thursday as we dig into all of the biggest news moving shares this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 21, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 20, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 15, 2024

Via Benzinga

CASI Stock Earnings: CASI Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024 ↗

May 14, 2024

CASI stock results show that CASI Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

CASI Stock Earnings: CASI Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023 ↗

March 28, 2024

CASI stock results show that CASI Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 08, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 07, 2024

Via Benzinga

CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients ↗

March 05, 2024

CASI Pharmaceuticals and BioInvent share promising results for BI-1206 in treating relapsed/refractory indolent Non-Hodgkin's Lymphoma patients in China. Preliminary data reveals clinical efficacy with...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 05, 2024

Via Benzinga

Week In Review: LianBio To Close Operations; Will Pay $528 Million To Shareholders ↗

February 17, 2024

LianBio, a Princeton-Shanghai biotech, has decided to call it quits. LianBio plans to stop all of its operations by the end of 2024, and it will distribute a $4.80 dividend/share ($528 million) to its...

Via Talk Markets

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 25, 2024

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for CASI Pharmaceuticals: Here's What You Need To Know ↗

November 15, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 03, 2023

Via Benzinga

Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

October 11, 2023

Gainers

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.